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Sonic hedgehog (Shh) has been reported to act as a mitogen and survival factor for muscle satellite cells. However, its role in their differentiation
remains ambiguous. Here, we provide evidence that Shh promotes the proliferation and differentiation of primary cultures of chicken adult myoblasts
(also termed satellite cells) and mouse myogenic C2 cells. These effects are reversed by cyclopamine, a specific chemical inhibitor of the Shh
pathway. In addition, we show that Shh and its downstream molecules are expressed in adult myoblast cultures and localize adjacent to Pax7 in
muscle sections. These gene expressions are regulated during postnatal muscle growth in chicks. Most importantly, we report that Shh induces
MAPK/ERK and phosphoinositide 3-kinase (PI3K)-dependent Akt phosphorylation and that activation of both signaling pathways is essential for
Shh's signaling in muscle cells. However, the effect of Shh on Akt phosphorylation is more robust than that on MAPK/ERK, and data suggest that
Shh influences these pathways in a manner similar to IGF-I. By exploiting specific chemical inhibitors of the MAPK/ERK and PI3K/Akt signaling
pathways, UO126 and Ly294002, respectively, we demonstrate that Shh-induced Akt phosphorylation, but not that ofMAPK/ERK, is required for its
promotive effects onmuscle cell proliferation and differentiation. Taken together, we suggest that Shh acts in an autocrinic manner in adult myoblasts,
and provide first evidence of a role for PI3K/Akt in Shh signaling during myoblast differentiation.
© 2007 Elsevier B.V. All rights reserved.Keywords: Sonic hedgehog; Satellite cells; Skeletal muscle; Differentiation; MAPK; Akt; Signal transduction1. Introduction
The ability of adult muscle tissue to grow or regenerate in
response to injury is dependent on the activation and prolifera-
tion of satellite cells (also termed adult myoblasts). These small
mononucleated cells lie under the basal lamina of the myofiber
and are present in the muscle mostly in their quiescent state [1].
Nevertheless, during growth or uponmuscle injury, satellite cells
become mitotically active, displaying programmed proliferation
and differentiation followed by expression of muscle-specific
proteins [2,3]. These processes are tightly regulated by the
muscle-specific helix–loop–helix MyoD family of proteins,
MyoD, myogenin, Myf5 and MRF4, and the myocyte enhancer-
binding factor 2 (MEF2) [4]. The pair-box transcription factor
Pax7 is specifically expressed in quiescent satellite cells and has
been shown to be co-expressed with MyoD during cell⁎ Corresponding author. Tel.: +972 8 9489204; fax: +972 8 9489337.
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doi:10.1016/j.bbamcr.2007.06.006proliferation and to decline when cells undergo differentiation
[5,6].
Several growth factors have been implicated in stimulating
or inhibiting satellite-cell proliferation and differentiation.
Among these factors are members of the fibroblast growth
factor family, insulin-like growth factor I and II (IGF-I and II),
transforming growth factor beta, platelet-derived growth factor
and hepatocyte growth factor (HGF) [3,7]. HGF has been
shown to act as an activator and a powerful mitogen for
satellite cells via the mitogen-activated protein kinase/extra-
cellular signal-regulated protein kinase (MAPK/ERK) pathway
[8–10]. Conversely, IGF-I, although serving as a mitogen, has
been reported to be more effective in inducing cell dif-
ferentiation and hypertrophy via the phosphoinositide 3′-kinase
(PI3K)/Akt pathway [11–15].
Recent reports have suggested that the embryonic factor sonic
hedgehog (Shh) plays a role in satellite cell proliferation and
differentiation [16,17]. In the embryo, Shh is expressed in the
notochord and neural floor plate and upregulates the formation
Table 1
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22]. Furthermore, Shh has been shown to stimulate the pro-
liferation and subsequent differentiation of already committed
myoblasts in the limb bud [23].
The intracellular mechanisms that mediate the actions of Shh
on target cells are only partially understood. Shh binding to its
receptor Patched (Ptch) relieves Ptch inhibition of an adjacent G-
protein-coupled membrane protein, smoothened (Smo). Once
activated, Smo induces a complex series of intracellular re-
actions that activate the Gli (glioma-associated oncogene)
protein(s) Gli-1, Gli-2 or Gli-3, for translocation to the nucleus
and regulation of target gene transcription, such as Ptch1, Gli,
and Wnt [24–27].
Shh and Ptch1 have been shown to be upregulated in re-
generating muscle following ischemia, suggesting that the
embryonic Shh pathway can be recapitulated in adults [28].
Further studies in mammals have reported the inductive effects
of Shh on satellite cell proliferation; however, its role in satellite
cell differentiation remains controversial: whereas some studies
show a direct effect of Shh on the induction of muscle cell
differentiation [16], others have reported its inhibitory effect
[17]. The present study was aimed at studying regulation of the
Shh pathway in myoblasts during the early growth phase in
posthatch chicks, as well as the role of Shh in the proliferation
and differentiation of muscle cells. We show that in primary
cultures of adult myoblasts derived from chicks at various days
of age, Shh, Ptch1 and Gli mRNA levels are upregulated in
parallel to the onset of myoblast differentiation. We found that
Shh induces both the proliferation and differentiation of
primary cultures of chicken myoblasts as well as of a mouse
myogenic cell line. We report here that whereas both MAPK/
ERK and PI3K/Akt signaling pathways are essential for Shh's
actions in muscle cells, the PI3K/Akt but not MAPK/ERK
pathway is directly involved in adult muscle cell proliferation
and differentiation.Summary of chicken and mouse primer sets used for RT-PCR
Gene Primers RT-PCR Size (bp)
Chick
GAPDH S: 5′-AGTCATCCCTGAGCTGAATG-3′ 330
AS: 5′-AGGATCAAGTCCACAACACG-3′
18S S: 5′-CGATGC TCT TAA CTG AGT GT-3′ 419
AS: 5′-TCA GCT TTG CAA CCATAC TC-3′
MHC S: 5′-GATCCAGCTGAGCCATGCCA-3′ 616
AS: 5′-GCTTCTGCTCAGCATCAACC-3′
Pax7 S: 5′-CCCAACCACATCCGCCATAAG-3′ 274
AS: 5′-AGTGTCCGTCCTTCAGCAGC-3′
MyoD S: 5′-CGTGAGCAGGAGGATGCATA-3 280
AS: 5′-GGGACATGTGGAGTTGTCTG-3′
Shh S: 5′-TGGAGGATATGAAGGGAAGA-3′ 553
AS: 5′-CTGAGTTTTCTGCTTTGACG-3′
Patch1 S: 5′-TCTTTTCCTGGGCTTACTTG-3′ 338
AS: 5′-TTTTCCCAGTTTCCCAGTCA-3′
Smo S: 5′-ATCCCAAAGTGCCTTCCAG-3′ 223
AS: 5′-GAGGAAGCCGTGAGCCTAC-3′
Mouse
GAPDH S: 5′-ACCACAGTCCATGCCATCAC-3′ 220
AS: 5′-TCCACCACCCTGTTGCTGTA-3′
Patch1 S: 5′-GAAGGCGCTAATGTTCTGAC-3′ 259
AS: 5′-TACCTAGGAGGTATGCTGTC-3′2. Materials and methods
2.1. Reagents
Dulbecco's Modified Eagle's Medium (DMEM), sera and antibiotic–
antimycotic solution were purchased from Biological Industries. UO126,
Ly294002, Wortmannin and urokinase (uPA) were obtained from Calbiochem.
Human recombinant pre-HGF and IGF-I were purchased from R&D Systems.
Mouse recombinant N-terminus active Shh (N-Shh) was prepared according to
a protocol kindly provided by David Bumcrot and Andrew McMahon
(Harvard University, Cambridge, MA). For further details see Bumcrot et al.
[29].
2.2. Cell cultures
C2 mouse myogenic cells [30] were grown in DMEM supplemented with
20% (v/v) fetal bovine serum (FBS). For the experiments, cells were plated
sparsely at 3×105 cells/100 mm Petri dish in growing medium for 1 day, after
which the medium was changed to serum-free DMEM and cells were incubated
for an additional 48 h. For experiments with HGF, pre-HGF was activated by
overnight cleavage with uPA (5.5 U/ng HGF) in 50 mM Tris–HCl buffer pH 8.8
containing 0.01% (v/v) Tween 20 at 37 °C [11].
Chicken skeletal muscle satellite cells were cultured from the pectoralis
muscle of 3-day-old chicks as described by Halevy and Lerman [31]. Cells wereplated at 5×104 cells/cm2 in DMEM supplemented with 10% (v/v) horse serum
(HS), and grown in culture. Cells were induced to differentiate in 2% HS. In
some experiments, freshly prepared cells were incubated for 1 day, and then
were rendered quiescent in serum-free DMEM for 40 h prior to treatment.
2.3. Muscle sampling for mRNA analysis and histology
Chick muscle samples were excised from the superficial regions of the
proximal one half of the left pectoralis major of each chick as previously
described [32]. Mouse (C57BL/6J strain) hindlimb muscle samples (Gastro-
cnemius) were excised from 7-week-old mice.
2.4. RNA preparation and RT-PCR
Total RNAwas prepared using TRIzol™Reagent (Invitrogen) and quantified
by spectrophotometric absorbance at 260 nm. Total RNA (1 μg) was reverse-
transcribed into cDNA using random primers and SuperScript reverse tran-
scriptase (Invitrogen). Polymerase chain reaction (PCR) was then performed
using Taq DNA polymerase (Fermentas) for each set of specific primers. Primer
sets and reaction conditions are summarized in Table 1. Either 18S or GAPDH
were used as internal controls to normalize the sample mRNA amounts. PCR
products were separated by electrophoresis and bands were visualized by video
camera (Dinco-Ranium). In addition, the identity of the corresponding genes was
verified by sequencing the PCR products.
2.5. Immunohistochemistry
Mouse muscle samples were fixed in fresh 4% (v/v) paraformaldehyde in
PBS solution (pH 7.4) for 24 h and embedded in paraffin and deparaffinized as
previously described [6]. Immunohistochemistry was performed as described in
Halevy et al. [6] with primary antibodies for Shh (1: 50) and Ptch1 (1: 50, Santa
Cruz), anti-Pax7 (1:2, Developmental Studies Hybridoma Bank, University
of Iowa, IA), and anti-laminin (1: 700, Sigma). Secondary antibodies were
rhodamine-conjugated donkey anti-goat IgG (1: 250, Jackson), Alexa Fluor 488
goat anti-rabbit IgG or Alexa Fluor 594 goat anti-rabbit (1:250, Molecular
Probes). Nuclei were detected with 4′6′-diamino-2-phenylindole (DAPI,
1 μg/ml). Sections were mounted in Vectashield (Vector Laboratories).
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Western blot and densitometric analyses were performed as described in [6].
Equal amounts of protein from muscle extracts were separated by SDS-PAGE
and transferred to nitrocellulose filters (Biorad). Membranes were incubated
overnight at 4°C with the appropriate antibodies, then washed and incubated for
1 h with horseradish peroxidase-conjugated goat anti-mouse or goat anti-rabbit
IgG (Zymed). The following primary antibodies were used: anti-phospho-
MAPK/ERK and anti-phospho-Akt antibodies, anti-total MAPK/ERK and Akt
polyclonal antibodies (Cell Signaling), anti-MEF2, anti-Ptch1 and anti-Smo
polyclonal antibodies and monoclonal anti-myogenin (Santa Cruz), monoclonal
anti-myosin heavy chain (MHC; MF20) and monoclonal anti-Pax7 (Hybridoma
Bank), and polyclonal anti-p21 andmonoclonal anti-p27 and anti-pRb antibodies
(BD Pharmingen) and monoclonal anti-α Tubulin antibody (Oncogene).
3. Results
3.1. The Shh pathway is regulated in muscle during the early
phase of postnatal growth
The regulation of Shh-cascade gene expression during
muscle development was analyzed in primary cultures of
myoblasts prepared from pectoralis muscles of pre- and
posthatch chicks. In late-term chick embryos, the muscle cell
population consists of fetal and adult myoblasts, whereas after
hatch, only adult myoblasts (satellite cells) are found [33,34].
Cells derived from muscles at various days of age were cultured
for 1 day, then harvested and the expression levels of MyoD,
Shh, Ptch1, Smo and Gli mRNA were analyzed by RT-PCR
(Fig. 1A). MyoD gene expression decreased towards hatch, then
increased until day 4 posthatch and declined on day 5,
indicating, as previously shown, high proliferative activity
followed by differentiation of adult myoblasts in chick muscle
on these days [35,36]. Shh, Ptch1, and Gli mRNAs were
expressed on all days, with a decrease in their expression levelsFig. 1. Temporal expression of Shh and its downstream molecules and muscle-
specific marker mRNA in myogenic cells prepared from pectoralis muscle of
pre- and posthatch chicks (A), during the differentiation of primary cultures of
muscle cells derived from 3-day-old chicks (B) and in pectoralis muscle tissues
sampled from pre and posthatch chicks (C). mRNA expression levels were
evaluated by semi-quantitative RT-PCR analysis using 18S or GAPDH as an
internal control. MT, myotubes.towards the end of the embryonic period and an increase in levels
from day 1; the Shh increase preceding that of Gli and Ptch1,
decreasing on day 5 (Fig. 1A). Smo expression remained
relatively constant throughout. The regulation of the Shh path-
way was analyzed during the proliferation and differentiation of
primary cultures of muscle cells derived from 3-day-old chick
pectoralis muscle. In these cultures, prepared with an exten-
sively-used protocol [6,10,31], over 95% of the mononucleated
cells express Pax7 [6], recently shown to be a marker for satellite
cells [5]. All genes except MHC were expressed in freshly
prepared cells (day 0; Fig. 1B). Shh mRNA levels increased in
the proliferating cells on day 1 and those of Ptch1 and Gli1
peaked the following day and then declined slightly in myo-
tubes. Shh levels decreased somewhat on day 2 and increased
again in the differentiated cells. Smo mRNA levels remained
comparable in both proliferating cells and myotubes, consistent
with the results shown in Fig. 1A. The proliferative state of the
cells was indicated by Pax7mRNA expression levels: these were
highest on day 0 and during the first 2 days in culture, then
declined when cells were switched to low-serum conditions to
differentiate and express high levels of MHC [6]. Fig. 1C
demonstrates that the kinetics of MyoD, Shh and Ptch1 mRNA
expression in pectoralis muscle tissue derived from pre- and
posthatch chicks is similar to that inmyoblasts (see Fig. 1A). The
upregulation in Shh mRNA expression levels in muscle on day 3
of age wasmore pronounced than that in themuscle cell cultures.
Along the same lines, Ptch1 protein expression was observed
in hindlimb muscle sections of 7-week-old mice and this
expression co-localized with that of laminin (Figs. 2A and B);
the latter is typically expressed in the basement membrane
surrounding the muscle fibers. Shh protein expression corre-
sponded to that of Ptch1 and co-localized with or adjacent to the
nuclei under the basal lamina (Fig. 2C). These nuclei appear to
be satellite cells as indicated by Pax7 expression which
corresponded with that of Shh (Figs. 2D–F). This is emphasized
in a higher magnification where Shh staining surrounds that of
Pax7 (Fig. 2G).
Addition of recombinant Shh (N-Shh) to primary cultures of
chick muscle cells, which had been rendered quiescent for 40 h
in serum-free medium, induced Ptch1 and Smo mRNA
expression at Shh concentrations as low as 0.5 μg/ml (Fig.
3A). Due to a lack of antibodies recognizing chicken Ptch1 and
Smo, the analysis at the protein expression level was conducted
in the mouse myogenic cell line C2 [30]. Addition of N-Shh to
serum-starved cells at various concentrations induced protein
expression levels of both Ptch1 and Smo in a dose-responsive
manner (Fig. 3B), suggesting that Shh-induced gene expression
is also regulated at the post-transcriptional level in muscle cells.
3.2. Shh promotes the proliferation and differentiation of adult
myoblasts
Shh has been shown to induce myoblast proliferation and
differentiation during limb development of chick embryos [23].
To examine Shh's potential effects on these processes in adult
myoblasts, we took advantage of both chick primary muscle
cultures and the mouse C2 cell line. Cells were rendered
Fig. 3. N-Shh induces Smo and Ptch1 gene expression in primary cultures of
adult myoblasts (A) and protein expression in C2 cells (B). Cells were rendered
quiescent for 40–48 h after which Shh was added at various concentrations for
an additional 24 h. mRNA expression levels were evaluated by semi-
quantitative RT-PCR analysis using 18S as an internal control. Protein
expression was analyzed by western blot analysis and protein loading quantity
is represented by α-Tubulin.
Fig. 2. Immunohistochemical localization of Ptch1 and Shh in the basement membrane of adult mouse muscle tissue. Sequential cross sections prepared from hindlimb
muscle of a 7-week-old mouse was immunostained for laminin (red, A) and Ptch1 (green, B), or for Shh (red, C). Counterstain was performed with DAPI to visualize all
nuclei (blue). Arrows indicate co-localization of Ptch1 and laminin. Arrowheads indicate Shh co-localization with or adjacent to the myonuclei. (D–F) Co-localization
of Shh (red) with Pax7 (green) as indicated by arrows and bymerge of Shh and Pax7 staining at higher magnification (G). Bar, 80 μm for A, B, D–F, 40 μm for C, 30 μm
for G.
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expression levels of myogenic factors (e.g., MyoD, data not
shown). In primary cultures of chickenmyoblasts, addition of N-
Shh at various concentrations for an additional 24 h enhanced the
mRNA-expression levels of Pax7, an early marker for muscle
cell proliferation [5,6], andMyoD, in a bell-shaped manner (Fig.
4A). These changes were more profound at the protein level of
Pax7 (Fig. 4B). Similarly, increased levels of thymidine
incorporation into DNA the chicken muscle cells were observed
in response to N-Shh (data not shown). In C2 cells, Pax7 protein
levels were induced in response to Shh in a bell-shape manner
(Fig. 4C, see also Fig. 4D). It should be noted that the difference
in overall Pax7 protein levels between chicken and C2 cells is
probably technical as the antibody against Pax7 was raised
against the chicken type.
The promotive effect of Shh on cell differentiation was
demonstrated by the upregulation of MHC mRNA myogenin
(Fig. 4A) and of MEF2 and MHC protein levels in the chicken
cells (Fig. 4B). Likewise, levels of cell cycle inhibitory proteins,
known to be upregulated during muscle cell differentiation [37–
40], were upregulated byN-Shh; p21 and p27 in chickmyoblasts
(Fig. 4B) and p27 and pRb in C2 myoblasts (Fig. 4C). Pax7 and
MHC protein expression was markedly reduced in C2 cells by
cyclopamine, a specific inhibitor of Smo and hence an inhibitor
of Shh signaling (Fig. 4D) [41], suggesting a specific action of
Shh in inducing muscle cell proliferation and differentiation.
3.3. Shh induces MAPK/ERK and Akt phosphorylation in adult
muscle cells
MAPK/ERK and PI3K/Akt signaling pathways play an
important role in muscle cell proliferation and differentiation.Moreover, these pathways have been shown to be essential for
Shh signaling in neural cells and chondrocytes [42,43]. We
tested whether these pathways play a role in Shh signaling in
adult myoblast proliferation and differentiation. Phosphoryla-
tion of Akt at 473Ser, using a phospho-specific antibody, pro-
vides a convenient marker for the extent of activation of the
PI3K pathway in vivo. N-Shh induced phosphorylation of Akt
in a dose–response manner in primary cultures of chicken
myoblasts and in the C2 cell line (Figs. 5A, C), and adminis-
tration of the PI3K inhibitor, Wortmannin, abolished this effect
(Fig. 5C), in agreement with previous studies [43,44]. Similarly,
N-Shh induced the phosphorylation of MAPK/ERK in both cell
Fig. 4. N-Shh promotes the proliferation and differentiation of chick adult myoblasts and C2 cells. (A) One-day cultures of chick muscle cells were incubated with
serum-free medium for 40 h after which N-Shh was added for an additional 24 h at various concentrations, and mRNA expression levels of Pax7, MyoD and MHC
were determined by RT-PCR. In a similar experiment, the protein expression of myogenic factors and cell-cycle proteins was analyzed by western blot in chick muscle
cells (B) and C2 cells (C), with or without cyclopamine (Cyclo, 1 μM) (D). α-Tubulin bands represent loaded protein quantity.
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UO126 (Figs. 5A, C, see also Fig. 6A). A time-course experi-
ment revealed that MAPK/ERK phosphorylation is induced
within 12 min. However, whereas its phosphorylation remained
high in the chick myoblasts up to 40 min (Fig. 5B), this effect
was very transient in C2 cells and the phosphorylation levels
were substantially reduced after 20 min (Fig. 5D). Akt phos-
phorylation was highly induced within 12 min of incubation
with Shh (1 μg/ml) in both chick myoblasts and mouse C2 cells
(Figs. 5B, D), and these phosphorylation levels remained high,
even after 120 min.
Reports on the direct effects of Shh on MAPK and PI3K
pathways are controversial. Whereas some indicate a direct
effect [43,44], others provide evidence of Shh's indirect co-Fig. 5. Shh induces MAPK/ERK and Akt phosphorylation in adult muscle cells. S
stimulated with various concentrations of Shh for 12 min (A and C) or with 1 μg/ml
and subjected to immunoblotting with anti-phospho-ERK1/2 antibody and anti-phos
demonstrated by Wortmannin (Wort, 100 nM) and UO126 (UO, 10 μM) treatment o
with anti-total ERK1/2 and anti-total Akt antibodies.operation with these signaling pathways [42,45]. Here, addition
of cyclopamine (1 μM), a specific inhibitor of Smo [41], to
serum-starved C2 cells in the presence of N-Shh inhibited the
Shh-induced MAPK/ERK and Akt phosphorylation (Fig. 6A).
Expression levels of Shh target gene, Ptch1, were reduced in
these cells in the presence of specific inhibitors of the MAPK/
ERK and PI3K/Akt pathways, UO126 and Ly294002, respec-
tively (Fig. 6B), suggesting that the Shh-induced effect on these
pathways is Smo-mediated.
We compared the effect of Shh on MAPK/ERK and Akt
phosphorylation in C2 cells vs. a human prostate cancer cell
line, PC3, known to respond to Shh [46]. As was shown in Figs.
5C, D, N-Shh induces MAPK/ERK and Akt phosphorylation
and this is inhibited by their specific inhibitors, UO126 anderum-starved chick muscle cells (A and B) or C2 myoblasts (C and D) were
Shh for the indicated times (B and D). Cell lysates were resolved by SDS-PAGE
pho-Akt antibody which recognizes P-473Ser. The specificity of this induction is
f cells 30 min prior to Shh (1 μg/ml) addition. Parallel membranes were probed
Fig. 7. Shh affects MAPK/ERK and Akt phosphorylation in a manner similar to
IGF-I. Serum-starved C2 cells were stimulated with 1 μg/ml Shh, 30 ng/ml HGF
or 7.5 ng/ml IGF-I for the indicated times. Cell lysates were resolved by SDS-
PAGE and subjected to immunoblotting with anti-phospho-ERK1/2 (A) and
anti-phospho-Akt antibodies (B). Parallel membranes were probed with anti-
total ERK1/2 and anti-total Akt antibodies.
Fig. 8. Shh effects on muscle cell differentiation are mediated via the PI3K/Akt
pathway. Serum-starved C2 cells were treated with or without 1 μg/ml Shh in the
presence or absence of UO126 (10 μM) and Ly294002 (25 μM) for 24 h.
Myogenic markers for proliferation and differentiation were analyzed by western
blot for Pax7, MEF2 and MHC. α-Tubulin bands represent loaded protein
quantity.
Fig. 6. MAPK/ERK and Akt phosphorylation is specifically induced by Shh in
muscle cells. (A) Addition of cyclopamine (Cyclo, 1 μM), a Smo-specific
inhibitor, abolishes the Shh-induced increase in MAPK/ERK and Akt
phosphorylation. (B) Inhibition of Shh-induced Ptch1 gene expression.
Serum-starved C2 cells were treated with or without 1 μg/ml Shh in the
presence or absence of UO126 (UO, 10 μM) and Ly294002 (Ly, 25 μM) for 24 h
and Ptch1 mRNA levels were analyzed by RT-PCR. (C) Comparison between
C2 and PC3 cells. Shh was added to serum-starved cells at various
concentrations C2 (left panel) and PC3 cells (right panel) for 12 min and
MAPK/ERK and Akt phosphorylation was analyzed by western blot using anti-
phospho-Akt and anti-phospho-MAPK antibodies. Wortmannin (Wort, 100 nM)
and UO126 (UO, 10 μM) were added 30 min prior to Shh (1 μg/ml) addition.
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Shh did not have any inductive effect on the phosphorylation of
these signaling molecules in PC3 cells (Fig. 6C, right panel),
suggesting that the effect of Shh on these signaling pathways is
cell-type specific.
3.4. Shh influences the MAPK/ERK and PI3K/Akt pathways in
a manner similar to IGF-I
Because Shh induced both MAPK/ERK and Akt phosphor-
ylation in muscle cells, we examined how Shh's effects relate to
those of other growth factors known to affect these pathways in
these cells. We performed a side-by-side comparison of the
abilities of Shh, HGF and IGF-I to activate these pathways in C2
myogenic cells; the latter two growth factors have been reported
to affect the MAPK/ERK and PI3K/Akt pathways [9,10,12] in
opposite ways [11]. A time-course experiment, using concentra-
tions that have been shown to be optimal for growth-factor
activity [11], clearly demonstrated substantially higher MAPK/
ERK phosphorylation levels in response to HGF relative to those
in response to IGF-I and Shh (Fig. 7A). Although the phos-
phorylation was highly transient in all cases, it lasted longer in
the case of HGF than in that of IGF-I or Shh.
An increase in Akt phosphorylation could be detected in
response to all factors within 5 min of incubation, with the
response to IGF-I being markedly higher than that to Shh or
HGF. However, in contrast to the case of HGF in which the Aktphosphorylation signal was highly transient, this signal
persisted for a longer period, up to 40 min, in response to
both Shh and IGF-I (Fig. 7B, see also Figs. 5B and D). Taken
together, these results suggest that Shh affects the MAPK/ERK
and PI3K/Akt pathways in a manner similar to IGF-I, albeit to a
lesser extent.
Next, we asked whether Shh-induced MAPK/ERK and Akt
phosphorylation is required for its inductive effects on muscle
cell proliferation and differentiation. To that end, specific in-
hibitors for the MAPK/ERK and PI3K/Akt signaling pathways,
UO126 and Ly294002, respectively, were added to serum-
starved C2 cells in the presence of N-Shh, and the expression of
muscle-specific proteins involved in cell proliferation and
differentiation was analyzed after 1 day. Ly294002 abolished
the Shh-induced stimulatory effect on all tested proteins-Pax7,
MEF2 and MHC (Fig. 8). However, UO126 administration only
slightly inhibited MEF2 and MHC, and had no effect on Pax7
expression levels.
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During early embryogenesis, Shh, secreted from the noto-
chord or neural floor plate, plays a crucial role in the formation
and survival of the dorsal myotome muscle-cell lineages
[18,20,22]. In adults, Shh has been reported to improve muscle
cell survival and proliferation; however its role in cell
differentiation remains ambiguous [16,17]. Our studies provide
evidence that Shh has a stimulatory effect on the proliferation
and differentiation of adult myoblasts. Moreover, Shh expres-
sion is found in the position of adult myoblasts in muscle. Its
transcript expression is regulated during muscle cell differentia-
tion and during early muscle growth in chicks.
Shh and Ptch1 mRNAs were expressed in myoblasts derived
from pectoralis muscles of late-term chick embryos, with an
increase in these mRNA levels in adult myoblasts in the days
posthatch. Previously, we reported that primary cultures of
chicken myoblasts strongly reflect the myogenic activity of
satellite cells in the muscle tissue, which peaks at around day 3
posthatch [6,36]. Indeed, Shh mRNA levels in the pectoralis
muscle tissue were markedly upregulated on day 3 posthatch,
postulating that most of the Shh in muscle is transcribed in adult
myoblasts. We do not exclude the possibility that in addition to
adult myoblasts, Shh is also produced and secreted from
interstitial cells, as previously reported by Pola et al. [28]. To
the best of our knowledge, Shh is not expressed in muscle
precursor cells during early embryogenesis. Hence, its expres-
sion found in late-term embryos can be attributed to the adult
myoblasts, being the majority of the myogenic cell population in
the muscle [33]. Moreover, Shh was found to be co-expressed
with Pax7 and its expression corresponded to that of Ptch1 and
laminin in postnatal mouse muscle sections. Together, these data
indicate that Shh is produced and secreted from adult myoblasts
to the basal lamina of the myofibers.
Our recent studies on the expression patterns of Pax7 and
myogenin in posthatch chicks led us to propose that on day 3
posthatch, some of the adult myoblasts are still proliferating
while others are expressing high levels of myogenin, indicating
the onset of cell differentiation in the muscle [6,32]. This process
then proceeds until day 8, when cell numbers decline drama-
tically [36]. Indeed, MyoD mRNA expression levels were still
high on day 3 posthatch (Figs. 1A, C), while those of Shh, Gli
and Ptch1 increased, in an expression dynamic consistent with
that of Shh and its target genes during differentiation of adult
myoblast cultures (Fig. 1B). Taken together, we suggest that the
expression of the Shh cascade is regulated during adult myoblast
proliferation and differentiation in muscle in the early growth
phase posthatch.
The findings that: (a) Shh is transcribed in primary cultures of
adult myoblasts, (b) the increase in Shh gene expression levels
precedes that of its target genes, Ptch1 and Gli1, during muscle
cell differentiation in culture (Fig. 1B) [27], (c) addition of N-
Shh induces Ptch1 mRNA and protein expression levels in
muscle cells (Fig. 3) [17], and (d) inhibition of Shh signaling
decreases the levels of its downstream genes in C2 cells (Fig.
4D) suggest that during the early phases of postnatal muscle
growth, Shh acts in an autocrinic manner as either a short-rangeor long-range molecule [47–49]. The autocrinic signaling of Shh
has been shown in odontogenesis [50] and in the promotion of
cancer development [51]. Taken together, these findings imply a
different mechanism of action for Shh in postnatal muscle as
opposed to embryonic muscle where Shh is secreted from
adjacent tissues and plays a role in myogenesis, thereby plays in
a paracrinic manner [18–20,22].
In light of the dynamics of Shh expression during muscle
growth of posthatch chicks and during muscle cell differentia-
tion, we suggest that Shh specifically affects adult muscle cell
proliferation and differentiation. Our view is further supported
by direct experiments in primary cultures of chicken cells as well
as in a mouse myogenic cell line. In both cell cultures, the
expression levels of Pax7, an early proliferation marker [6], and
thymidine incorporation by DNA (data not shown), were
stimulated in response to Shh, corroborating previous reports
on the stimulatory effect of Shh on muscle cell proliferation
[17,20,23]. Likewise, Shh increased the expression levels of
myogenic regulatory factors, as well as of MHC and cell-cycle
proteins involved in muscle cell differentiation [37–40]. Shh-
mediated induction of muscle markers was specific, as evi-
denced by cyclopamine's inhibitory effect. Whereas our results
on the effect of Shh on muscle cell differentiation corroborate
those published by Duprez et al. [23] and Li et al. [16], they
contradict other reports [17]. It may well be that in the latter
studies, the presence of different sera in the cultures affected the
cell's response to Shh. Here, as cells were rendered quiescent in
serum-free medium, there was no interference of growth factors
which could potentially mask the N-Shh effect on cell dif-
ferentiation. Moreover, we have reported that these cells retain
their capacity to return to the cell cycle, indicating that they have
not undergone spontaneous terminal differentiation [52,53].
Taken together, the dynamics of Shh and its downstream genes
in adult myoblasts of growing chicks and the stimulatory effect
of Shh on muscle differentiation markers (at the mRNA and
protein levels in two animal species) strongly suggest its
promotive effect on adult myoblast differentiation.
Shh is known to elicit its effects by binding to its receptor
Ptch1, thereby releasing Ptch1 inhibitory effect on the effector
Smo, which then transduces a signal for activation of Gli family
members. Although the mechanism of this signaling pathway
has not been fully elucidated, recent reports suggest that the
PI3K/Akt pathway is crucial for Shh signaling [43,44]. In this
study, we demonstrate for the first time the promotive effect of
Shh on MAPK/ERK and Akt phosphorylation, and its role in
regulating these pathways in adult muscle cells. Several lines of
evidence support our notion: (a) the regulation of MAPK/ERK
and Akt phosphorylation is demonstrated in dose-dependent and
time-course experiments in primary cultures of chicken adult
myoblasts as well as in mouse C2 cells (Fig. 5). It is unlikely that
Shh's stimulatory effect on these proteins' phosphorylation is
due to the nonspecific effects of growth factors present in the
medium as the cells were kept under serum-starved conditions
for a long period of time. (b) Under the same experimental
conditions, neither MAPK/ERK nor Akt phosphorylation was
detected in PC3 hepatocytes, known to respond to Shh [46],
suggesting the cell-type specificity of Shh's effects on MAPK
1445D. Elia et al. / Biochimica et Biophysica Acta 1773 (2007) 1438–1446and PI3K pathways. (c) Specific inhibitors of the MAPK/ERK
and PI3K pathways, as well as the Smo inhibitor, cyclopamine,
block the Shh-mediated induction of ERK and Akt phosphor-
ylation and the Shh target gene, Ptch1, in muscle cells. (d)
Finally, our results are in agreement with those presented earlier
for other cell systems [43,44,54]. Taken together, we propose
that in adult muscle cells, MAPK/ERK and PI3K/Akt cascades
are regulated downstream of Shh and are required for its sig-
naling pathway.
In muscle, PI3K/Akt signaling promotes cell survival as well
as differentiation and hypertrophy [13,14], whereas the MAPK/
ERK signaling pathway is pivotal for cell proliferation [10,55].
Does Shh transduce its effects on muscle cell proliferation and
differentiation via these pathways? Shh's effect on MAPK/ERK
phosphorylation was highly transient, particularly in the C2
cells, whereas Akt phosphorylation was high and sustained for
as long as 7 h of incubation. In addition, the time course of
MAPK/ERK and Akt phosphorylation in response to Shh was
more comparable to that of IGF-I, which induces differentiation
via the PI3K pathway [12–14], than to that of HGF, which
induces muscle cell proliferation mainly via the MAPK/ERK
pathway [10,11]. Moreover, we demonstrate that the specific
PI3K inhibitor Ly294002, but not the specific MAPK/ERK
inhibitor UO126, blocks Shh-mediated induction of muscle-
specific protein expression. In view of these findings, we suggest
that while Shh's effects on cell differentiation are directly
mediated via the PI3K/Akt pathway downstream of Smo,
MAPK/ERK probably does not mediate the promotive effects of
Shh on muscle cell proliferation. It may well be that other effects
of Shh (e.g. cell survival) [17,21] are mediated via the MAPK/
ERK pathway [56,57].
Our data support a role for Shh in promoting proliferation and
differentiation of adult muscle cells. By inducing its receptor,
Ptch1, Shh plays a role in cell proliferation, and by maintaining
high levels of Ptch1, Shh stimulates cell differentiation. Both the
MAPK/ERK and PI3K/Akt pathways are regulated by Shh and
are required for its effects on adult myoblasts. However, it
appears that the PI3K/Akt pathway mediates and is essential for
Shh-stimulated muscle cell differentiation, and is essential for
this process, whereas MAPK/ERK is less important. Collec-
tively, these data shed more light on the mechanism of action of
Shh in inducing proliferation and differentiation in postnatal
muscle.
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